What Is the Malignancy Risk in Neurofibromatosis Type 1?
J Clin Oncol
.
2016 Jun 10;34(17):1967-9.
doi: 10.1200/JCO.2016.66.8186.
Epub 2016 Mar 21.
Author
D Gareth R Evans
1
Affiliation
1
St Mary's Hospital, Central Manchester Hospitals Foundation Trust, Manchester, United Kingdom gareth.evans@cmft.nhs.uk.
PMID:
27001592
DOI:
10.1200/JCO.2016.66.8186
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Neurofibromatosis 1*
Risk